Emrald Medical Research Private Limited
About Emrald Medical Research Private Limited
Data last updated:
Emrald Medical Research Private Limited is a private limited company based in Aurangabad, Maharashtra, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 07 April 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U73100MH2010PTC201818. Its GSTIN is 27AACCE3562A1Z3 (Maharashtra).
The company has an authorised share capital of ₹17 Cr and a paid-up capital of ₹8.75 Cr. It is led by directors Shivaji Pandharinath Jawale and Girish Vallabh Mahale.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Gurudeo Appt. Flat No – 6 Manjeet Nagar Opp. Akashwani Jalna Road, Aurangabad, Maharashtra, India – 431001.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.68 Cr, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹24.57 Lakh (net margin 3.7%) and EBITDA of ₹1.23 Cr (EBITDA margin 18.4%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 22% over five years.
As per MCA filings, the company has open charges of ₹1 Cr and satisfied charges of ₹87.16 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Emrald Medical Research Private Limited's registered office is in Aurangabad, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressGurudeo Appt. Flat No – 6 Manjeet Nagar Opp. Akashwani Jalna Road, Aurangabad, Maharashtra, India – 431001
- IndustryHealthcare, Preventive Health Services
To see the full contact details of Emrald Medical Research Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Emrald Medical Research is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Emrald Medical Research Private Limited, buy the company report.
Financials of Emrald Medical Research Private Limited
FY 2025 filings availableEmrald Medical Research Private Limited reported revenue of ₹6.68 Cr (up 20% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 22% over five years, including 20% growth in the latest year. EBITDA rose 128% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.23 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹24.57 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 18.4% | ||||
| Net Profit Margin | 3.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Emrald Medical Research Private Limited, buy the company report.
Board of directors of Emrald Medical Research Private Limited
Emrald Medical Research has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shivaji Pandharinath Jawale | Director | 01 Oct 2024 | 2 Years 1 Months | Current |
| Girish Vallabh Mahale | Director | 30 Nov 2021 | 4 Years 11 Months | Current |
Auditor
Emrald Medical Research Private Limited is audited by Sabs & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Sabs & Associates | FY 2023 | 126840W |
Shareholding
The shareholding of Emrald Medical Research Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Emrald Medical Research Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Nov 2025 | 101189168 | Others | ₹50 Lakh | Open | |
| 12 Nov 2025 | 101189292 | Others | ₹50 Lakh | Open | |
| 01 Oct 2021 | 100492804 | Others | ₹2.06 Cr | Satisfied | |
| 26 Mar 2019 | 100252028 | The Pandharpur Urban Co-Op. Bank Ltd. | ₹40.1 Cr | Satisfied | |
| 11 Mar 2019 | 100250871 | Others | ₹45 Cr | Satisfied |
To see the full charge records of Emrald Medical Research Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
No court or tribunal cases involving Emrald Medical Research Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Emrald Medical Research Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Emrald Medical Research has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCE3562A1Z3 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Emrald Medical Research Private Limited, buy the company report.
Recent activity
Emrald Medical Research Private Limited has 5 board changes on record since 2010: 3 appointments and 2 cessations. The latest: Mandar Suresh Abhyankar ceased to be Director on 17 Oct 2024.
5 earlier events are in the company report.
Frequently asked questions
Emrald Medical Research is an active private limited company based in Aurangabad, Maharashtra, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 07 April 2010 (16+ years old) and is registered under CIN U73100MH2010PTC201818.
Emrald Medical Research has 2 current directors:
- Shivaji Pandharinath Jawale - Director
- Girish Vallabh Mahale - Director
The latest financial statements of Emrald Medical Research on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Emrald Medical Research is 27AACCE3562A1Z3, registered in Maharashtra.
The CIN (Corporate Identification Number) of Emrald Medical Research is U73100MH2010PTC201818. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Emrald Medical Research was incorporated on 07 April 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.
Mandar Suresh Abhyankar ceased to be Director on 17 Oct 2024. Shivaji Pandharinath Jawale was appointed as Director on 01 Oct 2024. Unmesh Vidyadhar Takalkar ceased to be Director on 03 Jan 2022. Emrald Medical Research has 5 board changes on record in total.
The registered office of Emrald Medical Research is at Gurudeo Appt. Flat No – 6 Manjeet Nagar Opp. Akashwani Jalna Road, Aurangabad, Maharashtra, India – 431001.
Emrald Medical Research operates in the healthcare industry, in the preventive health services segment.
Emrald Medical Research has open charges of ₹1 Cr and satisfied charges of ₹87.16 Cr as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
